Boston Scientific Misses 2026 Targets: Impact of Cyber Attack

Boston Scientific announced that it will fall short of its financial targets set for 2026. The company stated that the primary reason behind this negative outlook was a cyber attack. The attack adversely affected operations and the supply chain, which in turn dragged down revenue and profitability projections. Company management emphasized that they have conducted extensive efforts to mitigate the effects of the cyber attack and that systems have largely returned to normal, but the lost production and sales time cannot be recovered. Consequently, growth expectations for 2026 have been revised with a more cautious approach. Analysts point out that cyber attacks pose an increasing risk for medical technology companies. This incident at Boston Scientific once again highlights the importance of cybersecurity investments in the sector. Following this announcement, the company's stock price may come under pressure due to investor concerns. The company plans to offset losses by focusing on cost control and operational efficiency in the coming period. However, it is noted that several more quarters may be needed to clarify the full cost and long-term effects of the cyber attack. Boston Scientific's performance during this challenging period will be closely monitored by investors. This is not investment advice.